Colorado BioScience Association Applauds Suspension of the Medical Device Tax and Reauthorization of CHIP

Tuesday, January 23, 2018


Friday Policy Update 1/19/2018

Friday, January 19, 2018

Another week goes by and we continue to strongly advocate for the repeal of the medical device excise tax. This week in DC, the House passed the continuing resolution (CR) to fund the government until February 16th. Included in the CR is a 2-year retroactive suspension of the device tax and a 6-year reauthorization of Children’s Health Insurance Program (CHIP), the longest reauthorization in CHIP’s history. Both would have a significant positive impact to our industry. The bill is now in the Senate’s hands, which we anticipate a vote today before midnight. At this time, it is unclear if the Senate has enough votes to pass the CR. If the House version of the CR does not pass, Congress will look to pass a clean, multi-day CR and have further discussions on a larger package that would address immigration, budget caps, and other issues. If the multi-day CR is the route Congress takes, it is likely the medical device excise tax will not be included   

Millennials: Training Talent

Tuesday, January 16, 2018


Friday Policy Updates 1/12/2018

Friday, January 12, 2018

Continue Reading

RxRevu Unveils New SwiftRx® Platform at 36th Annual J.P.Morgan Healthcare Conference

Wednesday, January 10, 2018

RxRevu, the industry leader in Prescription Decision Support, will unveil its new SwiftRx® platform while attending the 36th Annual J.P.Morgan Healthcare Conference on January 8th in San Francisco, CA. Building on RxRevu’s proven success, this unique and revolutionary platform helps doctors choose which drug to prescribe through a proprietary guidance-based approach that considers the patients real-time cost and evidence-based clinical recommendations. The SwiftRx® platform is also the first to prospectively complete electronic prior authorizations (ePA) for prescriptions, eliminating a huge frustration of providers that has plagued the industry for years. 

miRagen: Comprehensive, microRNA Targeted Therapies

Tuesday, January 09, 2018


Inocucor Raises $9.5 Million in Series B Second Close Led by Pontifax AgTech, Raising Total Proceeds of Series B Financing to $38.5 Million

Monday, January 08, 2018

Inocucor Raises $9.5 Million USD ($12.1 Million CAD) in Series B Second Close Led by Pontifax AgTech, Raising Total Proceeds of Series B Financing to $38.5 Million USD ($50.9 Million CAD) 


Monday, January 08, 2018

Articulus Bio, LLC, a development-stage orthopedic medical device platform focused on total joint replacement, today announced that Adam B. Rubenstein, Chief Executive Officer, will present at the 10th annual Biotech Showcase Conference on Wednesday, January 10, 2018, at 3:15 p.m. PST. The conference is being held at the Hilton Union Square Hotel in San Francisco, California.  

Friday Policy Updates – 1/5/2018

Friday, January 05, 2018

Under the Gold Dome – The 71st General Assembly
Continue Reading

Millennials in Colorado

Wednesday, January 03, 2018